| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/24/1993 | WO1993012248A1 Ligands and binding partner for treatment and diagnosis of inflammatory conditions |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012239A1 Alteration of plant and plant cell growth characteristics |
| 06/24/1993 | WO1993012236A1 Constitutive expression of p450soy and ferredoxin-soy in streptomyces, and biotransformation of chemicals by recombinant organisms |
| 06/24/1993 | WO1993012234A1 Antiviral reagents based on rna-binding proteins |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012230A1 Triple-helix formation at (punpyn).(punpyn) tracts |
| 06/24/1993 | WO1993012228A1 Method for generating structural and functional diversity in a peptide sequence |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993012146A1 Trophoblast interferons and their use |
| 06/24/1993 | WO1993012145A1 Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| 06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
| 06/24/1993 | WO1993012141A1 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 06/24/1993 | WO1993012140A1 Peptide with cell adhesion activity and polymeric modification thereof |
| 06/24/1993 | WO1993012136A1 Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region |
| 06/24/1993 | WO1993012134A1 Diagnosis of hereditary retinal degenerative diseases |
| 06/24/1993 | WO1993012133A1 Transcriptional cofactor regulation of expression |
| 06/24/1993 | WO1993012129A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | WO1993012127A1 PLATELET GPIIIa P1?A1 AND P1A2¿ EPITOPES, THEIR PREPARATION AND USE |
| 06/24/1993 | WO1993011799A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011792A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 06/24/1993 | WO1993011791A1 Antigenic preparations that stimulate production of antibodies which bind to the pili of type iv piliated bacteria |
| 06/24/1993 | WO1993011790A1 Flea midgut-supernatant vaccines |
| 06/24/1993 | WO1993011784A1 Methods for inhibition or stimulation of the inflammatory response |
| 06/24/1993 | WO1993011783A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/24/1993 | WO1993011782A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 06/24/1993 | WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding |
| 06/24/1993 | WO1993011778A1 Bifunctional antithrombotic molecules and antithrombotic polypeptides |
| 06/24/1993 | WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/24/1993 | WO1993011257A3 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path |
| 06/24/1993 | DE4142452A1 Mittel zur stimulierung der teilungsaktivitaet tierischer zellen Means for stimulation of teilungsaktivitaet animal cells |
| 06/24/1993 | DE4141794A1 Removing protease and acetylated impurities from insulin |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125966A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | CA2125947A1 Constitutive expression of p450soy and ferredoxin-soy in streptomyces, and biotransformation of chemicals by recombinant organisms |
| 06/24/1993 | CA2125767A1 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 06/24/1993 | CA2125494A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/24/1993 | CA2125400A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | CA2125192A1 A process for generating a structural and functional diversity in a peptide sequence |
| 06/24/1993 | CA2125181A1 Trophoblast interferons and their use |
| 06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
| 06/24/1993 | CA2085828A1 Serpulina hyodysenteriae vaccine |
| 06/23/1993 | EP0548012A1 Endoplastic reticulum-located recombinant dibasic endoprotease and uses thereof |
| 06/23/1993 | EP0547932A1 Process for preparing an activated factor VII concentrate having a high purity |
| 06/23/1993 | EP0547873A2 A novel translational activating sequence |
| 06/23/1993 | EP0547689A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope |
| 06/23/1993 | EP0547681A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a lipopeptide |
| 06/23/1993 | EP0547544A2 Process for the preparation of insulin-containing solutions |
| 06/23/1993 | EP0547446A2 Vaccines based on modified bovine herpesvirus type I |
| 06/23/1993 | EP0547317A1 Endothelin antagonists |
| 06/23/1993 | EP0547201A1 Phagemide for screening antibodies |
| 06/23/1993 | EP0547200A1 Recombinant antibodies at the surface of e. coli |
| 06/23/1993 | EP0547180A1 Recombinant agents affecting thrombosis |
| 06/23/1993 | EP0547178A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 06/23/1993 | EP0547171A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 06/23/1993 | EP0547164A1 Methods for the diagnosis and treatment of diabetes |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547102A1 Solubilization of proteins in active forms |
| 06/23/1993 | EP0547065A1 Melanin production by transformed microorganisms |
| 06/23/1993 | EP0547059A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies. |
| 06/23/1993 | EP0263172B1 Protein analogues of tissue plasminogen activator |
| 06/23/1993 | EP0249635B1 Word recognition in a speech recognition system using data reduced word templates |
| 06/23/1993 | EP0236330B1 Dna sequence encoding a hirudin-like protein and process for preparing such protein |
| 06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
| 06/22/1993 | US5221778 Transgenic mouse carrying in genome transresponder transgene comprising gene of interest operably linked to promoter sequence regulated by viral gene product of Herpes simplex virus type I |
| 06/22/1993 | US5221752 α-keto amide derivatives |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/22/1993 | US5221738 cDNA and genomic DNA encoding the amino acid sequence of human α2 -plasmin inhibition |
| 06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
| 06/22/1993 | US5221734 Separation by chromatography |
| 06/22/1993 | US5221732 Peptide antibiotic |
| 06/22/1993 | US5221664 Inhibiting growth of a target cell or virus |
| 06/22/1993 | US5221624 DNA encoding (Lys46, Asp97, Asp113) and (Lys46, Asp.sup.137) thaumatin I polypeptides |
| 06/22/1993 | US5221620 Cloning and expression of transforming growth factor β2 |
| 06/22/1993 | US5221619 Method and means for microbial polypeptide expression |
| 06/22/1993 | US5221618 Genetic detoxification of pertussis toxin |
| 06/22/1993 | US5221607 Screening agents which affect amount of preamyloid deposits by culturing cells which express amyloid protein as insoluble aggregate, adding agent, determining effect |
| 06/22/1993 | CA1319337C Newcastle disease virus gene clones |
| 06/20/1993 | CA2058876A1 Cyclic hiv principal neutralizing determinant peptides |
| 06/19/1993 | WO1994004568A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2104099A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2085447A1 A novel translational activating sequence |
| 06/19/1993 | CA2085084A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope |
| 06/19/1993 | CA2085083A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide |
| 06/19/1993 | CA2059611A1 L-phenylalanyl-trna synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
| 06/18/1993 | EP0559834A4 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor. |
| 06/17/1993 | DE4240386A1 High purity, highly immunogenic hepatitis B vaccine - uses antigen isolated from human serum by affinity chromatography, induces antibodies in all subjects immunised |
| 06/17/1993 | DE4138621A1 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg A method for screening substances having a modulating effect on a cellular rezeptorabhaengigen signaluebertragungsweg |
| 06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
| 06/16/1993 | EP0547026A1 Gene coding for human colony-stimulating factors |
| 06/16/1993 | EP0546916A1 Method for the separation of lp(a) by electrophoresis, gels for the implementation of this method and its application to the in vitro determination of atherogenic risk linked to the presence of lp(a) |
| 06/16/1993 | EP0546813A2 Proteins for inhibiting adhesion of platelets to collagen |
| 06/16/1993 | EP0546787A2 Expression of specific immunogens using viral antigens |
| 06/16/1993 | EP0546393A1 Peptide synthesizer |
| 06/16/1993 | EP0546213A1 Biologically active polypeptide and antibacterial agent |
| 06/16/1993 | EP0546149A1 Nucleotide sequences hybridizable with the nov gene of chickens |